JRNGF(JRNGF)
JRNGF
No analyst ratings available
No analyst price targets available for JRNGF
Analyst coverage may not be available for this symbol
No recent analyst actions
| Metric | FY2026E | FY2027E | FY2028E | FY2029E |
|---|---|---|---|---|
| Revenue Avg | $155M | $220M | $249M | $281M |
| Low | $155M | $220M | $249M | $281M |
| High | $155M | $220M | $249M | $281M |
| EBITDA Avg | $76M | $108M | $122M | $138M |
| Low | $76M | $108M | $122M | $138M |
| High | $76M | $108M | $122M | $138M |
| EBIT Avg | $45M | $64M | $73M | $82M |
| Low | $45M | $64M | $73M | $82M |
| High | $45M | $64M | $73M | $82M |
| Net Income Avg | $24M | $24M | $14M | $20M |
| Low | $24M | $24M | $14M | $20M |
| High | $24M | $24M | $14M | $20M |
| EPS Avg | $0.36 | $0.36 | $0.20 | $0.30 |
| Low | $0.36 | $0.36 | $0.20 | $0.30 |
| High | $0.36 | $0.36 | $0.20 | $0.30 |
| Analysts (Rev / EPS) | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 |
|---|---|---|---|---|---|---|
| Revenue Avg | $34M | $35M | $36M | $37M | $38M | $39M |
| Low | $34M | $35M | $36M | $37M | $38M | $39M |
| High | $34M | $35M | $36M | $37M | $38M | $39M |
| EBITDA Avg | $17M | $17M | $18M | $18M | $19M | $19M |
| Low | $17M | $17M | $18M | $18M | $19M | $19M |
| High | $17M | $17M | $18M | $18M | $19M | $19M |
| EBIT Avg | $10M | $10M | $10M | $11M | $11M | $11M |
| Low | $10M | $10M | $10M | $11M | $11M | $11M |
| High | $10M | $10M | $10M | $11M | $11M | $11M |
| Net Income Avg | $11M | $10M | $9M | $7M | $7M | $8M |
| Low | $11M | $10M | $9M | $7M | $7M | $8M |
| High | $11M | $10M | $9M | $7M | $7M | $8M |
| EPS Avg | $0.16 | $0.16 | $0.13 | $0.10 | $0.10 | $0.12 |
| Low | $0.16 | $0.16 | $0.13 | $0.10 | $0.10 | $0.12 |
| High | $0.16 | $0.16 | $0.13 | $0.10 | $0.10 | $0.12 |
| Analysts (Rev / EPS) | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 |